June 18 (Reuters) - Caris Life Sciences' CAI.O shares jumped nearly 28.6% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025.
(Reporting by Pritam Biswas in Bengaluru; Editing by Shinjini Ganguli)
((Pritam.Biswas@thomsonreuters.com;))